Peptidylglycine α-amidating monooxygenase restores brain microvascular blood flow and improves recovery following ischemic stroke

Matson, E. R.; Ilina, Y.; Tsinoglou, A.; Attrill, E. H.; Mayne, S.; Ross, R. M.; Keske, M. A.; Sutherland, B. A.; Hampel, H.; Kaufmann, P.; Bergmann, A.; Premilovac, D.

doi:10.64898/2026.06.14.732201

bioRxiv · 10.64898/2026.06.14.732201

Peptidylglycine α-amidating monooxygenase restores brain microvascular blood flow and improves recovery following ischemic stroke

Matson, E. R.·Ilina, Y.·Tsinoglou, A.·Attrill, E. H.·Mayne, S.·Ross, R. M.·Keske, M. A.·Sutherland, B. A.·Hampel, H.·Kaufmann, P.·Bergmann, A.·Premilovac, D.

View original source ↗Export metadata ↓

Abstract

IntroductionReduced or absent capillary blood flow (termed no-reflow) even after arterial recanalization is associated with poorer neurological outcomes following ischemic stroke. The aim of the current study was to test whether acute administration of peptidylglycine -amidating monooxygenase (PAM) can increase capillary blood flow and improve brain recovery after ischemic stroke. MethodsA 60-minute ischemic stroke was induced using middle cerebral artery occlusion (MCAO) in rats. A modified, long-acting PAM enzyme was administered 30 minutes after induction of ischemia and rats were recovered for either 24 hours or 7 days. In all animals, real-time cerebral blood flow was assessed before, during and after MCAO using trasncranial contrast enhanced ultrasound (tCEU). For rats in the 7-day protocol, a modified neuroscore test was used to assess neurological deficit following MCAO. At the end of each experiment, a transcardiac perfusion was used to generate a fluorescent vascular cast and histology was used to examine capillary diameters and determine infarct volume. ResultsFollowing MCAO and arterial recanalization, untreated rats had reduced cerebral blood flow across brain regions affected by ischemia, indicative of no-reflow. PAM administration led to enhanced cerebral blood flow in affected regions, and this was associated with increased capillary diameters 24 hours after ischemic stroke. Although there was no difference in infarct volume at 24 hours, by day 7, infarct volume was markedly reduced in the PAM group and these animals exhibited improved neurological function compared to the untreated group. ConclusionAdministration of PAM improves capillary blood flow after ischemic stroke leading to enhanced neurological and brain recovery. This work highlights PAM as a novel theraputic approach to improve brain blood flow and recovery after ischemic stroke. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=110 SRC="FIGDIR/small/732201v1_ufig1.gif" ALT="Figure 1"> View larger version (36K): org.highwire.dtl.DTLVardef@3095ddorg.highwire.dtl.DTLVardef@1bf159borg.highwire.dtl.DTLVardef@239afdorg.highwire.dtl.DTLVardef@19476e3_HPS_FORMAT_FIGEXP M_FIG C_FIG

Explore related subjects

physiology Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Matson, E. R., Ilina, Y., Tsinoglou, A., Attrill, E. H., Mayne, S., Ross, R. M., Keske, M. A., Sutherland, B. A., Hampel, H., Kaufmann, P., Bergmann, A., Premilovac, D.. 2026-06-18. Peptidylglycine α-amidating monooxygenase restores brain microvascular blood flow and improves recovery following ischemic stroke. https://doi.org/10.64898/2026.06.14.732201

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Rad and Phospholamban are Key Drivers of the Ventricular Adrenergic Response and Stress-Induced Arrhythmia

The adrenergic response is a fundamental mechanism that regulates heart rate (chronotropy), cardiac contractility (inotropy) and relaxation (lusitropy). Adrenergic stress is also a recognized trigger of arrhythmia in disease. Yet, our understanding of the underlying molecular basis remains incomplete. Protein kinase A (PKA) and the calcium/calmodulin-dependent kinase II (CaMKII) phosphorylate multiple targets proposed to participate in the adrenergic response, including the GTP-binding protein Rad, phospholamban (PLB) and ryanodine receptor 2 (RyR2). Here we demonstrate that phosphorylation of both Rad and PLB is necessary for inotropy and lusitropy. We show that changes in cardiac contractility and relaxation are primarily dependent on intracellular calcium handling. Finally, we report that Rad and PLB control stress-induced arrhythmogenesis, despite the phosphorylation of other pro-arrhythmic targets. We have identified the essential molecular components of the adrenergic response, resolving a long-standing debate in cardiac excitation-contraction coupling and refining current models of sympathetic regulation in health and disease.

physiology↗

bioRxiv2026

MCT6 is an intestinal Lac-Phe exporter required for metformin-associated weight loss

Metabolites are increasingly recognized as circulating molecules that regulate physiology, yet the mechanisms that couple intracellular production to organism-wide action remain poorly defined. Using the anorexigenic metabolite Lac-Phe as a tractable system, we identify the orphan transporter MCT6 (SLC16A5) as a physiologic intestinal Lac-Phe exporter. This mechanism controls the extent to which intracellularly synthesized Lac-Phe acquires systemic activity. MCT6 transports Lac-Phe, mediates its cellular efflux, and is required for maintaining its blood levels in mice following strong glycolytic stimuli. Both global and intestinal epithelial-specific deletion of MCT6 confers resistance to metformin-associated weight loss on a high-fat diet. Bypassing the transport defect with exogenous Lac-Phe normalizes the body weight phenotype of MCT6-KO mice. Together, these data connect MCT6 to metformin pharmacology and intestinal lactate metabolism, and more generally underscore the importance of transporter-mediated release in the conversion of an intracellular metabolic state into a circulating metabolite effector.

physiology↗

bioRxiv2026

DEPP1 connects nutrient and oxygen availability to maintenance of muscle mass

Nutrients and oxygen are sensed within the muscle to control growth and disruption of either signal is sufficient to lead to muscle atrophy. While nutrient limitation is sensed via a conserved transcriptional atrophy program (commonly referred to as atrogenes) dictated via the Forkhead box O (FoxO) transcription factors, how low oxygen promotes muscle loss remains unknown. Accordingly, the downstream mechanisms that initiate muscle loss when oxygen and nutrients are limiting are only partly understood. Here, we find Hypoxia Inducible Factor (HIF), the master regulator of our adaptation to low oxygen, is necessary and sufficient to mediate muscle loss under hypoxia in mice. RNA sequencing in skeletal muscle isolated from starved or hypoxic mice identifies Decidual Protein Induced by Progesterone 1 (Depp1), which is induced in skeletal muscle when nutrients or oxygen is limiting via FoxO1 and HIF activation, respectively. Whole body Depp1 loss in mice reduces muscle loss under fasting and hypoxia and skeletal muscle Depp1 overexpression is sufficient to mediate muscle atrophy. Mechanistically, Depp1 localizes to the mitochondria and is necessary to control autophagy activation and mitochondrial degradation in skeletal muscle. Taken together, our studies nominate Depp1 as a new atrogene necessary for muscle loss under multiple atrophy scenarios involving FoxO and HIF.

physiology↗